Evidence map›Paper›PMID 23481666›Full record

Trial reportJournal of acquired immune deficiency syndromes (1999)2013

Neither microbial translocation nor TLR responsiveness are likely explanations for preexisting immune activation in women who subsequently acquired HIV in CAPRISA 004.

Vivek Naranbhai, Natasha Samsunder, Netanya G Sandler, Annalys Roque, Quarraisha Abdool Karim, Thumbi Ndungʼu, William H Carr, Marcus Altfeld, Daniel C Douek, Salim S Abdool Karim and 1 more

Abstract readClinical TrialRandomized Controlled Trial
In one paragraph

Trial report in Journal of acquired immune deficiency syndromes (1999), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Reduced immune activation during tenofovir-emtricitabine therapy in HIV-negative individuals.Journal of acquired immune deficiency syndromes (1999) · 2015
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Vivek NaranbhaiCentre for the AIDS Programme of Research in South Africa, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Natasha Samsunder
Netanya G Sandler
Annalys Roque
Quarraisha Abdool Karim
Thumbi Ndungʼu
William H Carr
Marcus Altfeld
Daniel C Douek
Salim S Abdool Karim
CAPRISA 004 Trial Team
Ragon Institute of MGH, MIT and Harvard · USNational Institutes of Health · USUniversity of KwaZulu-Natal · ZACentre for the AIDS Programme of Research in South Africa · ZAColumbia University · USNational Institute of Allergy and Infectious Diseases · US

Funding

The Viral Set Point in HIV-1 Subtype C InfectionU19AI051794 · NIAID · UNIVERSITY OF KWAZULU-NATAL · PI ABDOOL KARIM, SALIM S · 2002 to 2007
$22.5M
TUBERCULOSIS SUPPLEMENTD43TW000231 · FIC · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI ABDOOL KARIM, QUARRAISHA · 1993 to 2014
$13.1M
T Cell Immune Responses To HIV And Other PathogensZIAAI005033 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DOUEK, DANIEL CESAR · 2009 to 2025
$11.4M
AIDS-Restrictive Innate Immune MechanismsK01TW007793 · FIC · MASSACHUSETTS GENERAL HOSPITAL · PI CARR, WILLIAM H · 2008 to 2011
$489k
FIC NIH HHS D43 TW000231FIC NIH HHS K01 TW007793FIC NIH HHS K01-TW007793Howard Hughes Medical InstituteIntramural NIH HHSNIAID NIH HHS U19 AI051794
6 · The paper itself

Abstract

Innate immune activation was a strong predictor of HIV acquisition in women at risk for HIV in CAPRISA 004. Identifying the cause(s) of activation could enable targeted prevention interventions. In this study, plasma concentrations of lipopolysaccharide, soluble CD14, and intestinal fatty acid-binding protein did not differ between subjects who did or did not subsequently acquire HIV nor were these levels correlated with plasma cytokines or natural killer cell activation. There was no difference between HIV acquirers and non-acquirers in the chemokine and cytokine responses of peripheral blood mononuclear cells stimulated with TLR2, 4, or 7/8 agonists. Further studies are required.

Indexed as

Bacterial TranslocationLymphocyte ActivationAdenineAnti-HIV AgentsCytokinesFatty Acid-Binding ProteinsFemaleHIV-1HIV InfectionsHumansKiller Cells, NaturalLipopolysaccharide ReceptorsLipopolysaccharidesOrganophosphonatesTenofovirToll-Like Receptor 2AdenineAnti-HIV AgentsCytokinesFatty Acid-Binding ProteinsLipopolysaccharide ReceptorsLipopolysaccharidesOrganophosphonatesTenofovirTLR2 protein, humanTLR4 protein, humanTLR7 protein, humanTLR8 protein, humanToll-Like Receptor 2Toll-Like Receptor 4Toll-Like Receptor 7Toll-Like Receptor 8Toll-Like Receptors

Identifiers

PMID23481666
PMCPMC3683111
OpenAlexW2047396941

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.